Sort
82,697 grants matching “vaccine development”
Universal Attenuated Malaria Sporozoite Vaccine and Challenge System
$990,645Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2006 · AI
Discovery and Preclinical Development of Drugs for Anthrax, Plague and Tularemia
$990,493Christie G. Brouillette · University Of Alabama At Birmingham · U01 · FY2008 · AI
Colorado AMC REACH Hub
$990,415Richard C Duke · University Of Colorado Denver · U01 · FY2021 · HL
MECHANISMS OF VIRAL MEDIATED IMMUNE EVASION
$990,370Immune Disease Institute, Inc. · P01 · FY2000 · AI
Living in the post-Zika world: Impact of interactions between dengue and Zika viruses on diagnostics, antibody dynamics, and correlates of disease risk
$990,329Eva Harris · University Of California Berkeley · U01 · FY2024 · AI
Universal Attenuated Malaria Sporozoite Vaccine and Challenge System
$990,311Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2007 · AI
Administrative Core
$990,300Dennis L. Kasper · Harvard Medical School · U54 · FY2013 · AI
Clinic-Ready MACH-1 Gene Gun for delivery of a universal influenza DNA vaccine
$990,275Hannah Frizzell · Orlance, Inc. · R44 · FY2024 · AI
Ethical, Legal and Social Issues for Precision Medicine and Infectious Disease
$990,267Gail Geller · Johns Hopkins University · RM1 · FY2019 · HG
HRS Yrs 29-34: Covid Antibody Revision
$990,154David R. Weir · University Of Michigan At Ann Arbor · U01 · FY2022 · AG
Understanding Hemotopoietic Neoplasias using Humanized Mice
$990,065Richard A Flavell · Yale University · R01 · FY2012 · CA
An Adaptive Intervention Trial of Home Testing with Behavioral Nudges for Improving COVID-19 Testing and Prevention among People Affected by Diabetes
$990,010Mary Beth Weber · Emory University · U01 · FY2023 · DK
Marketing Strategic Plan and Distribution Logistics for Sanaria PfSPZ Vaccine against Malaria.
$989,914Stephen Lev Hoffman · Sanaria, Inc. · SB1 · FY2018 · AI
Development of three KSHV vaccine platforms and chimeric MHV68-K-G for in vivo mouse infection study
$989,903Jae U Jung · Cleveland Clinic Lerner Com-Cwru · U01 · FY2024 · CA
Durable HIV Vaccine Targeting Mucosal Epithelium
$989,873Marie-Claire Elisabeth Gauduin · Texas Biomedical Research Institute · R01 · FY2022 · AI
Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDS
$989,774Dhiraj Kumar Singh · Texas Biomedical Research Institute · R01 · FY2023 · AI
Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDS
$989,774Dhiraj Kumar Singh · Texas Biomedical Research Institute · R01 · FY2022 · AI
Vaccine Strategies for Candidal Infections
$989,750John P Hennessey · Novadigm Therapeutics, Inc. · R42 · FY2009 · AI
Immune responses to HPV infection and HPV vaccination
$989,576Mahboobeh Safaeian · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA
Malaria Transmission Blocking Vaccine Discovery
$989,562Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Genital Herpes Vaccine Discovery
$989,544Gary Fujii · Molecular Express, Inc. · R44 · FY2009 · AI
Point-of-care lateral flow immunoassay for diagnosis of pertussis
$989,461Amanda Burnham-Marusich · Dxdiscovery, Inc. · R44 · FY2025 · AI
Human Genetic Analysis Resource
$989,461Robert C. Elston · Case Western Reserve University · P41 · FY2009 · RR
Multivalent Adjuvant Immunization to Prevent Hospital Acquired Infections
$989,399Brad J Spellberg · Exbaq Llc · R42 · FY2023 · AI
Vaccine Research and Development for Endemic, Emerging, and Resurgent Viruses
$989,342Masaru Kanekiyo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI